Chi­na's KBP Bio is com­ing to Amer­i­ca, with $76M A round and GSK vet tak­ing the helm in Philly

Over the past 5 years KBP Bio­sciences has been steadi­ly grow­ing up its pipeline of new drugs from its base in Chi­na. But this morn­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA